186 related articles for article (PubMed ID: 21193542)
1. Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature.
Clayton RN; Raskauskiene D; Reulen RC; Jones PW
J Clin Endocrinol Metab; 2011 Mar; 96(3):632-42. PubMed ID: 21193542
[TBL] [Abstract][Full Text] [Related]
2. Complications and mortality of Cushing's disease: report on data collected over a 20-year period at a referral centre.
Mondin A; Ceccato F; Voltan G; Mazzeo P; Manara R; Denaro L; Scaroni C; Barbot M
Pituitary; 2023 Oct; 26(5):551-560. PubMed ID: 37495935
[TBL] [Abstract][Full Text] [Related]
3. The risk of COVID-19 in Cushing's disease is independently related to disease activity (hypercortisolism) and obesity.
M G Mascarenhas-Nakano B; R Correa-Silva S; Fracacio SMR; W Brock P; F Dias R; Binda ESS; Santos-Neto PF; Portari LHC; Sanudo A; Abucham J
Arch Endocrinol Metab; 2024 Mar; 68():e220313. PubMed ID: 38557479
[TBL] [Abstract][Full Text] [Related]
4. The Incidence of Pregnancy-Associated Cushing's Disease and Its Relation to Pregnancy: A Retrospective Study.
Tang K; Lu L; Feng M; Zhang H; Chen K; Sun X; Zhu H; Wang R; Lu Z
Front Endocrinol (Lausanne); 2020; 11():305. PubMed ID: 32547488
[No Abstract] [Full Text] [Related]
5. Excess mortality in patients with non-functioning pituitary adenoma: a systematic review and meta-analysis.
Bioletto F; Sibilla M; Gasco V; Ghigo E; Grottoli S
J Endocrinol Invest; 2024 Mar; ():. PubMed ID: 38503992
[TBL] [Abstract][Full Text] [Related]
6. Impact of etiology, sex, diabetes mellitus and remission status on erythrocytic profile in patients with cushing's syndrome: a large population database study.
Dery L; Stern J; Shimon I; Rudman Y; Kushnir S; Shochat T; Fleseriu M; Akirov A
Pituitary; 2024 May; ():. PubMed ID: 38769229
[TBL] [Abstract][Full Text] [Related]
7. Elevated Mortality Rate in Patients With Functional Seizures After Diagnosis and Referral.
Kerr WT; Patterson EH; O'Sullivan IM; Horbatch FJ; Darpel KA; Patel PS; Robinson-Mayer N; Winder GS; Beimer NJ
Neurol Clin Pract; 2024 Apr; 14(2):e200227. PubMed ID: 38223352
[TBL] [Abstract][Full Text] [Related]
8. The Treatment of Cushing's Disease.
Pivonello R; De Leo M; Cozzolino A; Colao A
Endocr Rev; 2015 Aug; 36(4):385-486. PubMed ID: 26067718
[TBL] [Abstract][Full Text] [Related]
9. Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.
Dekkers OM; Horváth-Puhó E; Jørgensen JO; Cannegieter SC; Ehrenstein V; Vandenbroucke JP; Pereira AM; Sørensen HT
J Clin Endocrinol Metab; 2013 Jun; 98(6):2277-84. PubMed ID: 23533241
[TBL] [Abstract][Full Text] [Related]
10. Complications of Cushing's syndrome: state of the art.
Pivonello R; Isidori AM; De Martino MC; Newell-Price J; Biller BM; Colao A
Lancet Diabetes Endocrinol; 2016 Jul; 4(7):611-29. PubMed ID: 27177728
[TBL] [Abstract][Full Text] [Related]
11. Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up.
Ntali G; Asimakopoulou A; Siamatras T; Komninos J; Vassiliadi D; Tzanela M; Tsagarakis S; Grossman AB; Wass JA; Karavitaki N
Eur J Endocrinol; 2013 Nov; 169(5):715-23. PubMed ID: 23996696
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.
Nieman LK; Biller BM; Findling JW; Murad MH; Newell-Price J; Savage MO; Tabarin A;
J Clin Endocrinol Metab; 2015 Aug; 100(8):2807-31. PubMed ID: 26222757
[TBL] [Abstract][Full Text] [Related]
13. Cushing's syndrome: a practical approach to diagnosis and differential diagnoses.
Pappachan JM; Hariman C; Edavalath M; Waldron J; Hanna FW
J Clin Pathol; 2017 Apr; 70(4):350-359. PubMed ID: 28069628
[TBL] [Abstract][Full Text] [Related]
14. Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome.
Fleseriu M; Biller BM; Findling JW; Molitch ME; Schteingart DE; Gross C;
J Clin Endocrinol Metab; 2012 Jun; 97(6):2039-49. PubMed ID: 22466348
[TBL] [Abstract][Full Text] [Related]
15. Mortality in Cushing's syndrome: a systematic review and meta-analysis.
Graversen D; Vestergaard P; Stochholm K; Gravholt CH; Jørgensen JO
Eur J Intern Med; 2012 Apr; 23(3):278-82. PubMed ID: 22385888
[TBL] [Abstract][Full Text] [Related]
16. Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study.
Clayton RN; Jones PW; Reulen RC; Stewart PM; Hassan-Smith ZK; Ntali G; Karavitaki N; Dekkers OM; Pereira AM; Bolland M; Holdaway I; Lindholm J
Lancet Diabetes Endocrinol; 2016 Jul; 4(7):569-76. PubMed ID: 27265184
[TBL] [Abstract][Full Text] [Related]
17. Should Cushing's Syndrome be Considered as a Disease with High Cardiovascular Risk in Relevant Guidelines?
Koracevic G; Stojkovic M; Lovic D; Pavlovic M; Kostic T; Kutlesic M; Micic S; Koracevic M; Djordjevic M
Curr Vasc Pharmacol; 2020; 18(1):12-24. PubMed ID: 30289080
[TBL] [Abstract][Full Text] [Related]
18. The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.
Isidori AM; Graziadio C; Paragliola RM; Cozzolino A; Ambrogio AG; Colao A; Corsello SM; Pivonello R;
J Hypertens; 2015 Jan; 33(1):44-60. PubMed ID: 25415766
[TBL] [Abstract][Full Text] [Related]
19. Metabolic and cardiovascular outcomes in patients with Cushing's syndrome of different aetiologies during active disease and 1 year after remission.
Giordano R; Picu A; Marinazzo E; D'Angelo V; Berardelli R; Karamouzis I; Forno D; Zinnà D; Maccario M; Ghigo E; Arvat E
Clin Endocrinol (Oxf); 2011 Sep; 75(3):354-60. PubMed ID: 21521323
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and mortality of Cushing's syndrome.
Hakami OA; Ahmed S; Karavitaki N
Best Pract Res Clin Endocrinol Metab; 2021 Jan; 35(1):101521. PubMed ID: 33766428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
